A McMaster team of researchers has found how the COVID-19 vaccines that use adenovirus vectors trigger a rare but sometimes fatal blood clotting reaction called vaccine-induced immune thrombotic thrombocytopenia or VITT.
Behind the scenes at the McMaster Platelet Immunology Laboratory, scientists are studying a cell so tiny it was once called 'blood dust'.
Can the antibodies in the blood plasma of COVID-19 survivors help others suffering from the disease? A McMaster researcher is at the forefront of one of the world’s largest clinical trials of a potential treatment for COVID-19.